10yrs or More
|HCF Quality (4.8)||(4.8)|
|Alfa Vitamins Soy Lecithin (3.1)||(3.1)|
|Youthful Mind (2.9)||(2.9)|
|GNLD NeoLife Mind Enhancement Complex (2.4)||(2.4)|
Ginkgoforce is a single ingredient herbal supplement designed to particularly help patients suffering from Raynaud’s Syndrome and tinnitus. Ginkgo biloba supplements are frequently prescribed treatments for these two conditions. The formula is sold under the A. Vogel brand which commercializes many other nutraceuticals, mostly herbal based.
Ginkgoforce delivers 90mg of active substance per tablet and the daily recommended dose is of 2-4 tablets. This means that by complying with the manufacturer’s recommendations, users will get 180-360 mg of Ginkgo extract. In the clinical trials involving Ginkgo biloba supplements as potential treatments for the conditions mentioned above dosages of 120-360 mg (for Raynaud’s) and 240 mg (for tinnitus) were used. So we can say that A. Vogel’s formula is able to deliver adequate amounts of its key ingredient to reduce the symptoms of the diseases which it is advertised for.
The product is addressed only to adults over 18 years old, except pregnant and nursing women, people suffering from bleeding conditions, and people programmed for any medical intervention.
Ginkgoforce contains the following ingredients: Ginkgoforce contains the following ingredients: Ginkgo biloba L. fresh leaf (3-5:1), ethanol 60% m/m, microcrystalline cellulose, soy polysaccharide, and Magnesium Stearate (vegetable source).
Ginkgo has been traditionally used for thousands of years in the treatment of various health problems like: asthma, skin conditions, tuberculosis, or fluid discharges. Modern medicine has found new uses for this highly researched herb, but some scientists believe that many of its traditional uses have been forgotten.
Nowadays, Ginkgo supplements are mainly advertised as memory enhancers. Another popular use is in the maintenance and optimization of circulatory system functions where it acts as a vasodilator and increases both oxygen and blood flow to the heart and organs. Ginkgo biloba is also being investigated as a potential adjuvant in the treatment of cancer, eye conditions, multiple sclerosis, pulmonary interstitial fibrosis, hearing loss, or mood disorders (anxiety, depression)
Human trials are numerous and have managed to offer some evidence of the extract’s health benefits. Studies involving memory impaired patients (including individuals diagnosed with Alzheimer’s disease or dementia) are the most abundant, so the evidence in this area is the most convincing. Unfortunately, for many of the other potential uses there is simply not enough relevant data to support the benefit claims issued by herbalists and naturopaths. Many of the human trials conducted so far don’t last long enough, include a low number of participants, or result in inconclusive findings. Because of this they cannot be used as valid evidence of Ginkgo’s safety and potency.
- Ginkgoforce contains a single key ingredient which has been the subject of numerous human clinical trials
- The price for a month supply is not high ($20).
- The formula is currently unavailable for purchase directly from the manufacturer’s website (out of stock) with no indication as to when it will be available again.
- There is no mentioning of a money-back guarantee for this formula
Ginkgoforce is a very simple nutritional supplement in terms of composition. A single key ingredient is included in the formula, so users don’t have to worry about potential ingredient interactions. The product can however interact with the active chemicals of other drugs, mainly blood-thinning medication. Certain side-effects are possible to occur, although highly improbable. Some of these include digestive discomfort, nausea, allergic reactions, skin problems (itching, rash), or headaches. We advise consumers to watch out for any of these symptoms and if they persist, immediately discontinue use and turn to specialized advice.
The number of consumer testimonials referring to this particular formula is very limited at this time. There is also no evidence that the product itself was used in any of the existing clinical trials.